C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2662508
Methods of utilizing biomarkers to identify patients for treatment or to monitor response to treatment are taught herein. Alterations in levels of gene expression of the biomarkers, particularly in response to Raf kinase inhibition, are measured and identifications or adjustments may be made accordingly.
La présente invention concerne des procédés d'utilisation de biomarqueurs pour identifier des patients pour un traitement ou pour suivre la réponse au traitement. Des altérations dans les niveaux de l'expression génétique des biomarqueurs, en particulier en réponse à l'inhibition de la Raf kinase, sont mesurées et des identifications ou des ajustements peuvent être effectués en conséquence.
Aardalen Kim
Aziz Natasha
Heise Carla
Moler Edward
Stuart Darrin
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Biomarkers of target modulation, efficacy, diagnosis and/or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biomarkers of target modulation, efficacy, diagnosis and/or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers of target modulation, efficacy, diagnosis and/or... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1761333